Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $4.15 | Change: $-0.12 | %Change: -2.81%
Volume: 10,127 | Day High/Low: 4.24/4.14 | 52 Week High/Low: 10.36/2.50
View modes: 
3.5 stars

RE:RE:Even if

Sweet jasus. Illegal insider trading is the most egregreious of equity violations. It is sanctified shareholder rape, if not challenged. We know there was short term news leaks, judging from the...read more
2 stars

RE:RE:RE:RE:RE:News item...Is now the time to buy?

The presumption is that pollen levels have exceeded the threshold level, at which a signjifcant allergic response is elicited. Perhaps that was the case for all temporal groups. But, the spring was...read more
3 stars

RE:RE:RE:RE:News item...Is now the time to buy?

The point about 120 subjects enroled by June 30 is potentially quite important. They might also check for number enroled by May 31. They could do t- tests on these partial samples of the kind...read more
1 star

RE:Even if

I have to agree. Unless we truly want an unplanned shakeup of the board, I don't see how proving insider trading would be to our benefit.  rate and reply
5 stars

RE:NRI Looking Good Here

Looks totally sold out.  rate and reply
1 star

Even if

insider knowledge and trading could be proven, what would that net the shareholders? They released the findings almost immediately upon receiving them, which caused lots of grumblimg on this board.  rate and reply
3 stars

RE:RE:RE:News item...Is now the time to buy?

There is also the manufacturing plant in Leipzig Germany. Re a stratified breakdown of the 2014 trial data, there were 120 patients selected by June 30/14. I gather, most of the remainder were...read more
3 stars

RE:RE:RE:RE:Insider Trades

Monies were granted to Nuvo in 2012 to further the development of WF10. Nuvo and its Leipzig immunology Group then partnered with Franhofer ( see below ). So, Nuvo management would have known the...read more
5 stars

RE:RE:RE:Insider Trades

consultant99 wrote: It is if you can prove it. Consider this....which is right? Management was totally oblivious to the weather risk on the trial. Management was aware that weather could...read more
5 stars

NRI Looking Good Here

Close over 4.37 is the key  rate and reply
5 stars

Nuvo Research May Be Worth The Risk Now

http://seekingalpha.com/article/2902106-nuvo-research-may-be-worth-the-risk-now  rate and reply
5 stars

Benefit of Multiple Test Centers

If the study is broken down regionally and compared to regional pollen data the findings may prove positively that WF10 has efficacy versus placebo, albeit with a smaller sample size than anticipated....read more
3 stars

RE:RE:RE:RE:Insider Trades

The exchange rules are quite clear about insider trading. It isnt permitted in the case of material news. The WF10 results were very material. The question becomes, who supervised those trials and...read more
1 star

Unbelievable

A lot of the same posters who called for a hundred bucks a share and dissed any naysayers on the bulletin board are now pointing fingers and shaking fists.  rate and reply
3 stars

RE:RE:RE:Insider Trades

Normally management must impose a blackout when anticipating material news. For example, a share buyback cannot proceed when it precedes a quarterly report by a month or two. Its obvious that they...read more
3.5 stars

RE:RE:News item...Is now the time to buy?

It sort of gets it half right. He mentions none of the other assets, other than P2 and WF10. He left out the manufacturing plant which seems to be running up to  $20 million per year output. He...read more
2.5 stars

RE:RE:Insider Trades

It is if you can prove it. Consider this....which is right? Management was totally oblivious to the weather risk on the trial. Management was aware that weather could play a role in the test...read more
3 stars

RE:RE:RE:Insider Trades

Insider trading is not a matter of how many shares they trade, it's that it took place at all, no matter how may shares are traded. This should be looked into, as the information/study documents were...read more
5 stars

RE:News item...Is now the time to buy?

That pretty much summarizes the cautious viewpoint of this stock. His DD seems a bit lacking, but at least we finally see an article that correctly points out the trial's failure doesn't necessarily...read more
5 stars

News item...Is now the time to buy?

http://seekingalpha.com/author/michael-colavecchia-cfa  rate and reply